Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-06-29
2000-03-21
Fan, Jane
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5462741, A61K 3144, C07D40104
Patent
active
060403209
ABSTRACT:
This invention relates to substituted imidazoles of Formula I ##STR1## pharmaceutical compositions containing them, methods of using them and intermediates useful in their manufacture. The compounds of the invention modulate the production of a number of inflammatory cytokines, and are useful in the treatment of diseases associated with the production of inflammatory cytokines.
REFERENCES:
patent: 3772441 (1973-11-01), Lombardino et al.
patent: 3929807 (1975-12-01), Fitz
patent: 3940486 (1976-02-01), Fitzi
patent: 4159338 (1979-06-01), Cherkofsky et al.
patent: 4175127 (1979-11-01), Bender et al.
patent: 4182769 (1980-01-01), Cherkofsky et al.
patent: 4190666 (1980-02-01), Cherkofsky et al.
patent: 4272543 (1981-06-01), Niedballa et al.
patent: 4330552 (1982-05-01), Cherkofsky
patent: 4348404 (1982-09-01), Whitney
patent: 4372964 (1983-02-01), Adams et al.
patent: 4440776 (1984-04-01), Niedballa et al.
patent: 4503065 (1985-03-01), Wilkerson
patent: 4528298 (1985-07-01), Niedballa et al.
patent: 4608382 (1986-08-01), Ferrini et al.
patent: 4780470 (1988-11-01), Bender et al.
patent: 5593991 (1997-01-01), Adams et al.
patent: 5593992 (1997-01-01), Adams et al.
patent: 5633377 (1997-05-01), Thurkauf et al.
patent: 5656644 (1997-08-01), Adams et al.
patent: 5670527 (1997-09-01), Adams et al.
patent: 5686455 (1997-11-01), Adams et al.
Charles, A. Dinarello, Inflammatory cytokines: interleukin-1 and tumor necrosis factor as Effector molecules in autoimmune diseases, Immunology 1991, 3:941-948.
Jeffrey C. Boehm et al., 1-Substituted 4-Aryl-5-pyridinylimidazoles: A New Class of Cytokine Suppressive Drugs with Low 5-Lipoxygenase and Cyclooxygenase Inhibitory Potency, J. Med Chem., 1996, 39, 3929-3937.
Alison M. Badger et al., Pharmacological Profile of SB 203580, a Selective Inhibitor of Cytokine Suppressive Binding Protein/p38 Kinase, in Animal Models of Arthritis, Bone Resorption, Endotoxin Shock and Immune Function, The Journal of Pharmacology and Experimental Therapeutics 279 1453-1461, 1996.
Michael J. Elliott et al., Treatment of Rheumatoid Arthritis with Chimeric Monoclonal Antibodies to Tumor Necrosis Factor, Arthritis & Rheumatism vol. 36 No.12, Dec. 1993, pp.1681-1690.
Don E. Griswold and Peter R. Young, Pharmacology of Cytokine Suppressive Anti-Inflammatory Drug Binding Protein (CSBP), a Novel Stress-Induced Kinase, Pharmacology Communications, 1996, vol. 7, pp. 323-329.
Beers Scott A.
Malloy Elizabeth A.
Wachter Michael P.
Wu Wei
Fan Jane
Harbour John
Ortho-McNeil Pharmaceutical , Inc.
LandOfFree
2-substituted imidazoles useful in the treatment of inflammatory does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-substituted imidazoles useful in the treatment of inflammatory, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-substituted imidazoles useful in the treatment of inflammatory will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-730600